About Bio-Path
Overview
Leadership
Scientifc Advisory Board
Directors
Partnering Opportunities
Technology
Pipeline
Pipeline
Prexigebersen
BP1001-A
BP1002
BP1003
Patients
Investors
Overview
SEC Filings
Corporate Governance
Media
Press Releases
Events
Presentations & Publications
Careers
Contact Us
SEC Form 10-K: For the fiscal year ended December 31, 2024
BPTH_Form_10-K_20250327
SEC Form 8-K: Press Release dated March 18, 2025
BPTH_20250318_8-K
SEC Form 8-K: Entry into a Material Definitive Agreement
BPTH_8-K_20250307
SEC Form 8-K
BPTH_20250217_8-K
SEC Form S-1/A
BPTH._S-1_A _20250212
SEC Form S-1
BPTH_S-1_20250121
SEC Form 8-K: Press Release dated January10, 2025
BPTH_20250110_8-K
SEC Form 8-K: Press Release dated December 19, 2024
BPTH_20241219_8-K
SEC Form 8-K: Other Items
BPTH_24-31094-1_D1.2_20241213
Download
SEC Form 8-K: Press Release dated December 11, 2024
BPTH_20241212_8-K
About Bio-Path
Overview
Leadership
Scientifc Advisory Board
Directors
Partnering Opportunities
Technology
Pipeline
Pipeline
Prexigebersen
BP1001-A
BP1002
BP1003
Patients
Investors
Overview
SEC Filings
Corporate Governance
Media
Press Releases
Events
Presentations & Publications
Careers
Contact Us